CT-020420

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameCT-020420
Drug Alias NameCT-0093 seriesCT-020420
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMembrane-associated progesterone receptor component 1 antagonistsBeta amyloid A4 protein inhibitors
TargetsMembrane-associated progesterone receptor component 1Beta amyloid A4 protein
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCognition Therapeutics Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCognition Therapeutics Llc
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A